scholarly journals Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse

2016 ◽  
Vol 35 (5) ◽  
pp. 671-678 ◽  
Author(s):  
Jussi O. Ropponen ◽  
Mikko A. Keränen ◽  
Alireza Raissadati ◽  
Antti I. Nykänen ◽  
Rainer Krebs ◽  
...  
2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
G. Wetzel ◽  
B. Relja ◽  
A. Klarner ◽  
D. Henrich ◽  
N. Dehne ◽  
...  

Background. Hypoxia-inducible factor-1α(HIF-1α) and NF-κB play important roles in the inflammatory response after hemorrhagic shock and resuscitation (H/R). Here, the role of myeloid HIF-1αin liver hypoxia, injury, and inflammation after H/R with special regard to NF-κB activation was studied.Methods. Mice with a conditional HIF-1αknockout (KO) in myeloid cell-line and wild-type (WT) controls were hemorrhaged for 90 min (30±2 mm Hg) and resuscitated. Controls underwent only surgical procedures.Results. After six hours, H/R enhanced the expression of HIF-1α-induced genes vascular endothelial growth factor (VEGF) and adrenomedullin (ADM). In KO mice, this was not observed. H/R-induced liver injury in HIF-1αKO was comparable to WT. Elevated plasma interleukin-6 (IL-6) levels after H/R were not reduced by HIF-1αKO. Local hepatic hypoxia was not significantly reduced in HIF-1αKO compared to controls after H/R. H/R-induced NF-κB phosphorylation in liver did not significantly differ between WT and KO.Conclusions. Here, deleting HIF-1αin myeloid cells and thereby in Kupffer cells was not protective after H/R. This data indicates that other factors, such as NF-κB, due to its upregulated phosphorylation in WT and KO mice, contrary to HIF-1α, are rather key modulators of inflammation after H/R in our model.


2012 ◽  
Vol 10 (1) ◽  
pp. 104 ◽  
Author(s):  
Michael A Palladino ◽  
Anoop Shah ◽  
Rebecca Tyson ◽  
Jaclyn Horvath ◽  
Christine Dugan ◽  
...  

2005 ◽  
Vol 280 (10) ◽  
pp. 9336-9344 ◽  
Author(s):  
Jean-Pascal Piret ◽  
Emmanuel Minet ◽  
Jean-Philippe Cosse ◽  
Noelle Ninane ◽  
Christophe Debacq ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (12) ◽  
pp. e0190074 ◽  
Author(s):  
Veronika Bäcker ◽  
Fung-Yi Cheung ◽  
Jens T. Siveke ◽  
Joachim Fandrey ◽  
Sandra Winning

2006 ◽  
Vol 291 (1) ◽  
pp. C104-C113 ◽  
Author(s):  
Tomoyuki Oda ◽  
Kiichi Hirota ◽  
Kenichiro Nishi ◽  
Satoshi Takabuchi ◽  
Seiko Oda ◽  
...  

Monocytes/macrophages of the myeloid lineage are the main cellular effectors of innate immunity. Hypoxia-inducible factor 1 (HIF-1) is essential for myeloid cell activation in response to inflammatory stimuli. However, it has not been established whether HIF-1 activity is induced during differentiation from monocyte to macrophage. We demonstrate that macrophage differentiation of THP-1 cells or monocytes from peripheral blood induces increased expression of both HIF-1α and HIF-1β as well as increased HIF-1 transcriptional activity leading to increased expression of HIF-1 target genes. The increased HIF-1 activity in differentiated THP-1 cells resulted from the combined effect of increased HIF-1α mRNA levels and increased HIF-1α protein synthesis. Differentiation-induced HIF-1α protein and mRNA and HIF-1-dependent gene expression was blocked by treating cells with an inhibitor of the protein kinase C or MAP kinase signaling pathway. THP-1 cell differentiation was also associated with increased phosphorylation of the translational regulatory proteins p70 S6 kinase, S6 ribosomal protein, eukaryotic initiation factor 4E, and 4E binding protein 1, thus providing a possible mechanism for the modulation of HIF-1α protein synthesis. RNA interference studies demonstrated that HIF-1α is dispensable for macrophage differentiation but is required for functional maturation.


2007 ◽  
Vol 43 ◽  
pp. 105-120 ◽  
Author(s):  
Michael L. Paffett ◽  
Benjimen R. Walker

Several molecular and cellular adaptive mechanisms to hypoxia exist within the vasculature. Many of these processes involve oxygen sensing which is transduced into mediators of vasoconstriction in the pulmonary circulation and vasodilation in the systemic circulation. A variety of oxygen-responsive pathways, such as HIF (hypoxia-inducible factor)-1 and HOs (haem oxygenases), contribute to the overall adaptive process during hypoxia and are currently an area of intense research. Generation of ROS (reactive oxygen species) may also differentially regulate vascular tone in these circulations. Potential candidates underlying the divergent responses between the systemic and pulmonary circulations may include Nox (NADPH oxidase)-derived ROS and mitochondrial-derived ROS. In addition to alterations in ROS production governing vascular tone in the hypoxic setting, other vascular adaptations are likely to be involved. HPV (hypoxic pulmonary vasoconstriction) and CH (chronic hypoxia)-induced alterations in cellular proliferation, ionic conductances and changes in the contractile apparatus sensitivity to calcium, all occur as adaptive processes within the vasculature.


2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
J. Guihaire ◽  
R. Itagaki ◽  
T. Deuse ◽  
X. Hua ◽  
M. Stubbendorff ◽  
...  

2020 ◽  
Author(s):  
Lungwani Muungo

Tumor hypoxia and hypoxia-inducible factor 1 (HIF-1) activationare associated with cancer progression. Here, we demonstrate thatthe transcription factor TAp73 opposes HIF-1 activity through anontranscriptional mechanism, thus affecting tumor angiogenesis.TAp73-deficient mice have an increased incidence of spontaneousand chemically induced tumors that also display enhanced vascularization.Mechanistically, TAp73 interacts with the regulatory subunit(α) of HIF-1 and recruits mouse double minute 2 homolog intothe protein complex, thus promoting HIF-1α polyubiquitination andconsequent proteasomal degradation in an oxygen-independentmanner. In human lung cancer datasets, TAp73 strongly predictsgood patient prognosis, and its expression is associated with lowHIF-1 activation and angiogenesis. Our findings, supported by invivo and clinical evidence, demonstrate a mechanism for oxygenindependentHIF-1 regulation, which has important implicationsfor individualizing therapies in patients with cancer.


Sign in / Sign up

Export Citation Format

Share Document